Ariane at ASTRO 2025 – San Francisco

28 September – 1 October 2025
Moscone Centre, San Francisco

Ariane was proud to attend the American Society for Radiation Oncology (ASTRO) Annual Conference 2025, one of the world’s leading gatherings in the field of radiation oncology. Representing Ariane, Mark Davies-Cousins, VP International Sales, was on hand to connect with clinicians and partners from across the globe.

A highlight of the conference was an insightful presentation from Dr. Barbet (Macon & Villeurbanne), who shared a detailed update on the latest results from the OPERA trial, reinforcing the growing clinical evidence for Papillon CXB.

Mark also met with clinicians from New York and Hong Kong, both of whom will soon begin offering Papillon CXB as part of their planned cancer treatment programmes — a clear signal of the continued global expansion of this targeted therapy.

We are delighted to see Papillon CXB gaining momentum internationally and thank all partners and clinicians who continue to support and advocate for this innovative approach to cancer treatment.

For more information on Papillon CXB and its clinical applications, please contact:

Mark Davies-Cousins
VP International Sales
mark.davies@arianemedicalsystems.com